Clinical Trial Update: The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compares paclitaxel monotherapy to paclitaxel plus carboplatin as neoadjuvant chemotherapy in patients with advanced ovarian cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Ovarian Cancer | Phase 2 | Status: NOT_YET_RECRUITING